According to COMPASS Pathways's latest financial reports the company has a price-to-book ratio of 2.41.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.40 | 27.21% |
2022-12-31 | 1.89 | -41.84% |
2021-12-31 | 3.24 | -62.76% |
2020-12-31 | 8.71 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.43 | 0.88% | ๐บ๐ธ USA |